Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
International Journal of Cancer Research
  Year: 2006 | Volume: 2 | Issue: 2 | Page No.: 176-187
DOI: 10.3923/ijcr.2006.176.187
Tumor Vasculature: The Achilles` Heel of Cancer ?
Simone Mocellin

Abstract:
Given its pivotal role in growth and survival, the tumor vasculature represents an attractive target for anticancer therapy. Over the last few decades, rapid progress has been achieved in the understanding of tumor angiogenesis including signaling pathways and their regulation. This has enabled the development of numerous potentially effective vasculature-targeted anticancer drugs (VTAD), which are being tested in the clinical setting. In this review I will focus on the most promising and advanced drugs targeting the tumor vasculature, briefly summarizing their mechanism of action and the clinical results so far obtained.
 [Fulltext PDF]   [Fulltext HTML]   [XML: Abstract + References]   [References]   [View Citation]  [Report Citation]
 RELATED ARTICLES:
  •    AT1 Receptors Activation Enhances the Expression of MMP-2, MMP-13 and VEGF but not MMP-9 in B16F10 Melanoma Cells
  •    Alzheimer’s Disease: Current Status of Etiopathogenesis and Therapeutic Strategies
  •    Serum Copper and Vascular Endothelial Growth Factor (VEGF-A) in Dysfunctional Uterine Bleeding
How to cite this article:

Simone Mocellin , 2006. Tumor Vasculature: The Achilles` Heel of Cancer ?. International Journal of Cancer Research, 2: 176-187.

DOI: 10.3923/ijcr.2006.176.187

URL: https://scialert.net/abstract/?doi=ijcr.2006.176.187

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 

Curve Bottom